ArticleEuropean journal of case reports in internal medicine2025
Raynaud's Phenomenon and Pericardial Effusion Requiring Management with A Pericardial Window as the only Manifestations of Systemic Sclerosis without Scleroderma for over 10 Years, after which Pulmonary Hypertension Developed.
Article in European journal of case reports in internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease characterised by vasculopathy and progressive fibrosis affecting the skin and internal organs. Systemic sclerosis sine scleroderma (ssSSc) is an uncommon variant, accounting for 5-10% of cases and is defined by the absence of cutaneous involvement despite internal organ manifestations. Case description: We present a case of a patient who initially presented with recurrent pericardial effusion and late-onset Raynaud's phenomenon. Despite serological markers, SSc was not diagnosed, due to absence of skin involvement, until pulmonary hypertension (PH) developed over a decade later. Nailfold capillaroscopy confirmed ssSSc. Surgical pericardial drainage and targeted PH therapy led to clinical improvement. Discussion: Pericardial effusion may be an early and under-recognised manifestation of ssSSc. While typically attributed to inflammation, our patient had a transudative effusion with a poor response to steroids, suggesting a non-inflammatory mechanism. The effusion preceded PH by over a decade, challenging current pathophysiological theories. Surgical drainage was effective, contrasting with poorer outcomes in cutaneous SSc. Conclusion: This case highlights the diagnostic complexity and heterogeneity of cardiac involvement in ssSSc. It underscores the importance of maintaining a high index of suspicion in patients with unexplained cardiopulmonary symptoms and demonstrates the indolent course of the disease in atypical SSc. LEARNING POINTS: Systemic sclerosis sine scleroderma (ssSSc) may be diagnosed late due to the absence of skin involvement, underscoring the need for clinical vigilance.Visceral manifestations can precede Raynaud's phenomenon, challenging the traditional diagnostic sequence in systemic sclerosis.Pericardial effusion may be an early and under-recognised feature of ssSSc, often presenting with non-specific symptoms and requiring a high index of suspicion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.